Fulgent Genetics, Inc. (FLGT) Income Quarterly - Discounting Cash Flows
FLGT
Fulgent Genetics, Inc.
FLGT (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q4)
12-31
2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
Report Filing 2026-02-27 2026-02-27 2025-11-07 2025-08-01 2025-05-02 2025-02-28 2024-11-08
1234
Revenue 322.7 83.34 84.07 81.8 73.46 76.21 71.74
1234
Cost of Revenue 191.8 50.75 48.56 47.37 45.12 44.37 44.97
1234
Gross Profit 130.9 32.58 35.51 34.44 28.35 31.85 26.77
1234
Operating Expenses 222 68.82 50.86 54.15 48.14 47.98 43.85
1234
Research & Development 53.91 14.17 13.86 13.48 12.39 12.11 11.78
1234
Selling, General and Administrative 160 52.62 34.98 38.68 33.76 33.88 30.07
1234
Other Operating Expenses 8.03 2.03 2.02 1.99 1.99 1.99 1.99
1234
Operating Income -91.1 -36.24 -15.35 -19.71 -19.8 -16.14 -17.08
1234
Net Non-Operating Interest 30.73 6.8 7.85 8.07 8 8.08 8.08
1234
Interest Income 30.92 6.94 7.87 8.09 8.02 8.29 8.09
1234
Interest Expense 0.193 0.134 0.028 0.017 0.014 0.21 0.014
1234
Equity & Other Income/(Expense) -8.29 0.162 1.36 -9.88 0.068 0.007 -9.53
1234
Income Before Tax -68.66 -29.27 -6.14 -21.52 -11.72 -8.04 -18.53
1234
Income Tax Expense -7.03 -5.62 0.683 -2.26 0.176 -1.85 -3.84
1234
Income Attributable to Non-Controlling Interest -1.12 -0.232 -0.218 -0.299 -0.369 -0.302 -0.046
1234
Net Income -60.51 -23.42 -6.61 -18.96 -11.53 -5.89 -14.65
1234
Depreciation and Amortization 24.12 6.11 6.04 6.05 5.92 6.19 5.92
1234
EBITDA -66.97 -30.13 -9.31 -13.66 -13.88 -9.94 -11.16
1234
Earnings Per Share (EPS) -1.95 -0.76 -0.21 -0.61 -0.37 -0.19 -0.48
1234
Diluted Earnings Per Share -1.95 -0.76 -0.21 -0.61 -0.37 -0.19 -0.48
1234
Weighted Average Shares Outstanding 30.78 30.78 30.75 30.83 30.83 30.65 30.42
1234
Diluted Weighted Average Shares Outstanding 30.78 30.78 30.75 30.83 30.83 30.65 30.42
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program